Cargando…
Placenta-derived IL-32β activates neutrophils to promote preeclampsia development
Immune activation at the maternal-fetal interface is a main pathogenic factor of preeclampsia (PE). Neutrophils (PMNs) are activated in PE patients, but the mechanism and consequences of PMN activation need to be further explored. Here, we demonstrated that interleukin-32 (IL-32) expression was sign...
Autores principales: | Liu, Dan, Li, Qiang, Ding, Hailin, Zhao, Guangfeng, Wang, Zhiyin, Cao, Chenrui, Dai, Yimin, Zheng, Mingming, Zhu, Xiangyu, Wu, Qianwen, Wang, Ya, Duan, Honglei, Tang, Huirong, Lu, Xianyan, Hou, Yayi, Hu, Yali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115232/ https://www.ncbi.nlm.nih.gov/pubmed/33707686 http://dx.doi.org/10.1038/s41423-021-00636-5 |
Ejemplares similares
-
Pravastatin alleviates lipopolysaccharide-induced placental TLR4 over-activation and promotes uterine arteriole remodeling without impairing rat fetal development
por: Yang, Muyi, et al.
Publicado: (2018) -
Effect of Placenta Previa on Preeclampsia
por: Ying, Hao, et al.
Publicado: (2016) -
Study of Histopathological Changes in the Placenta in Preeclampsia
por: Bhojwani, Kashish, et al.
Publicado: (2022) -
Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia
por: Shen, Pei, et al.
Publicado: (2012) -
Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies
por: Huang, Jin, et al.
Publicado: (2020)